AIC
SGMO

AWM Investment Company’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

AWM Investment Company’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-92,200
Closed -$534K – 105
2016
Q2 		$534K Hold
92,200
– – 0.11% 85
2016
Q1 		$558K Hold
92,200
– – 0.12% 86
2015
Q4 		$842K Hold
92,200
– – 0.17% 82
2015
Q3 		$520K Sell
92,200
-70,000
-43% -$577K 0.1% 105
2015
Q2 		$1.8M Sell
162,200
-10,000
-6% -$129K 0.26% 85
2015
Q1 		$2.7M Sell
172,200
-287,800
-63% -$4.45M 0.37% 78
2014
Q4 		$7M Buy
+460,000
New +$5.59M 0.95% 39

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

AWM Investment Company's SGMO Position: Q3 2016 in Review

AWM Investment Company sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2016, closing a stake of 92,200 shares — an estimated $534K sold.

AWM Investment Company first reported a position in SGMO in Q4 2014 and held it in 7 quarters. The position peaked at $7M in Q4 2014. 124 funds tracked by Wall St. Rank hold SGMO as of Q3 2016.

  • AWM Investment Company reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
  • AWM Investment Company sold 92,200 SANGAMO THERAPEUTICS INC shares in Q3 2016, an estimated $534K.
  • AWM Investment Company first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and held it in 7 quarters.
  • AWM Investment Company's SANGAMO THERAPEUTICS INC position peaked at $7M in Q4 2014.
  • 124 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2016.

Based on AWM Investment Company's 13F filing for Q3 2016, filed 14 Nov 2016.